Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays-Reference-Cited by-同舟云学术

Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays

Published:2017-12 Issue: Volume:40 Page:73-80
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

de Medeiros Ana Santos,Wyman Arlene R.,Alaamery Manal A.,Allain Christina,Ivey F. Douglas,Wang Lili,Le Hai,Morken James P.^ORCID,Habara Alawi,Le Cuong,Cui Shuaiying^ORCID,Lerner Adam^ORCID,Hoffman Charles S.^ORCID

Funder

Boston College

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology

Reference45 articles.

1. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use;Bender;Pharmacol. Rev.,2006

2. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling;Conti;Annu. Rev. Biochem.,2007

3. Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies;Lerner;Biochem. J.,2006

4. Advances in targeting cyclic nucleotide phosphodiesterases;Maurice;Nat. Rev. Drug Discov.,2014

5. Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies;Sadana;Neurosignals,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases;European Journal of Medicinal Chemistry;2024-05

2. Advances in the development of phosphodiesterase 7 inhibitors;European Journal of Medicinal Chemistry;2023-03

3. Evaluation of Known Human PDE Inhibitors Against Nematode PDE4s;2023-02-24

4. Phosphodiesterase inhibitors and lung diseases;Advances in Pharmacology;2023

5. Use of a Fission Yeast Platform to Identify and Characterize Small Molecule PDE Inhibitors;Frontiers in Pharmacology;2022-01-17